查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600641

伴同性动物药品市场：依产品类型、适应症、动物类型、通路 - 2025-2030 年全球预测

Companion Animal Pharmaceuticals Market by Product (Analgesics, Anti-infectives, Anti-inflammatory), Indication (Behavioral Disorders, Dermatologic Diseases, Infectious Diseases), Animal Type, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年伴同性动物药品市场价值为143.9亿美元，预计到2024年将达到152.8亿美元，复合年增长率为6.67%，预计到2030年将达到226.2亿美元。

伴同性动物药品市场包括专为宠物（包括狗、猫和其他家畜）设计的药品和药物，包括疼痛管理、疫苗接种、感染疾病、疫苗、抗寄生虫药物和皮肤病学等医疗需求。 。在将宠物视为家庭成员以及对动物健康和保健的兴趣的人性化趋势的推动下，随着全球宠物拥有的增加，这一领域变得越来越重要。兽医学的进步、宠物保健意识的提高以及宠物相关服务支出能力的提高推动了需求。准入市场延伸至兽医院、家庭药局、网路销售平台。关键的成长要素包括宠物拥有量的增加、兽医基础设施的蓬勃发展、药物配方的技术进步以及慢性宠物疾病的快速增加。机会包括注射剂的口服替代品的开发、针对个别动物的个人化医疗，以及宠物拥有量不断增加的新兴市场的成长机会。然而，他们面临药品价格上涨、药品审批严格的监管要求以及阻碍采用的药物潜在副作用等障碍。经济放缓将影响宠物医疗保健支出，并对市场扩张构成进一步挑战。创新可以围绕着开发环保、安全和具有成本效益的药物，以及利用生物技术开发新型疗法。製药公司和兽医医院之间的合作研究可能会在治疗效果和安全性方面带来突破。补充药品的治疗性营养和保健产品的趋势预计也将推动市场开拓。该市场具有竞争性和动态性，其特点是技术快速进步和饲主偏好不断变化，需要即时市场分析和适应性策略来应对不断变化的人口统计和不断变化的消费者需求。成功地将技术创新与消费者需求结合的公司可望占领重要的市场占有率。

主要市场统计
基准年[2023] 143.9亿美元
预测年份 [2024] 152.8亿美元
预测年份 [2030] 226.2亿美元
复合年增长率（%） 6.67%

市场动态：快速发展的伴同性动物药品市场的关键市场洞察

供需的动态交互作用正在改变伴同性动物药物市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 通用和慢性感染疾病的盛行率不断增加
    • 伴同性动物数量和卫生意识的增加
    • 提高大众对动物保健的认识和支出
  • 市场限制因素
    • 与伴同性动物健康 API 相关的一些风险因素
  • 市场机会
    • 伴同性动物新药和疫苗的开发
    • 新兴经济体市场参与者与策略联盟的出现
  • 市场挑战
    • 严格药品核准相关规定

波特五力：驾驭伴同性动物药品市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解伴同性动物药品市场的外部影响

外部宏观环境因素在塑造伴同性动物药品市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解伴同性动物药物市场的竞争状况

对伴同性动物药品市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵伴同性动物药品市场供应商的绩效评估

FPNV 定位矩阵是评估伴同性动物药品市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 通用和慢性感染疾病的盛行率增加
      • 宠物数量的增加和卫生意识的增加
      • 提高大众对动物保健的认识和支出
    • 抑制因素
      • 与宠物动物用药品相关的一些风险因素
    • 机会
      • 宠物新药和疫苗的开发
      • 新兴经济体市场参与者的出现与策略合作
    • 任务
      • 药品核准严格规定
  • 市场区隔分析
    • 产品：多种止痛药，用于治疗宠物的一般疼痛和慢性疼痛
    • 适应症：日益关注开发宠物抗菌素抗药性和感染疾病的先进药物
    • 动物类型：越来越多的人引入狗作为宠物，其治疗费用也在增加。
    • 分销管道：提高透过线上管道获取伴同性动物药品的可近性和便利性
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化

第六章伴同性动物药品市场：副产品

  • 止痛药
  • 抗感染
  • 发炎（药
  • 医药添加剂和饲料添加剂
  • 寄生剂
  • 疫苗

第七章伴同性动物药品市场适应症

  • 行为障碍
  • 皮肤病
  • 感染疾病
  • 整形外科疾病
  • 疼痛

第八章依动物类型分類的伴同性动物药品市场

  • 猫
  • 狗
  • 马

第九章伴同性动物药品市场：依通路分类

  • 网路药房
  • 零售药房
  • 兽医诊所
  • 动物医院

第十章美洲伴同性动物药品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区伴同性动物药品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲伴同性动物药品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 勃林格殷格翰在印度推出 NexGard SPECTRA，这是一种为狗提供全面寄生虫保护的新型咀嚼解决方案
    • Zoetis 获得 FDA核准突破性犬骨关节炎和过敏治疗
    • Axton Biosciences 将重点转向宠物健康并利用尖端技术开发新治疗方法
    • Zoetis 透过收购 Jurox 扩大全球影响力，加强宠物和牲畜护理动物医药产品组合

公司名单

  • Phibro Animal Health Corporation
  • Hipra Laboratories, SA
  • Vetneeds Group
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Tianjin Ringpu Biotechnology Co., Ltd.
  • Stanex Drugs and Chemicals Pvt Ltd.
  • Indian Immunologicals Ltd.
  • Alivira Animal Health Limited
  • Kyoritsu Seiyaku Corporation
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • SkyEc Pharmaceuticals Private Limited
  • Endovac Animal Health, LLC
  • Lutim Pharma Pvt. Ltd.
  • Virbac SA
  • Ceva Sante Animale
  • Meiji Group
  • Boehringer Ingelheim International GmbH
  • Century Pharmaceuticals Ltd.
  • Zydus Animal Health
  • Vetbiolix
  • Merck & Co. Inc.
  • Veko Care
  • Ashish Life Science Pvt. Ltd.
  • Chanelle Pharma
  • Zoetis Inc.
  • Hester Biosciences Limited
  • Orion Corporation
  • Eco Animal Health Group PLC
Product Code: MRR-FD3F12D52B58

The Companion Animal Pharmaceuticals Market was valued at USD 14.39 billion in 2023, expected to reach USD 15.28 billion in 2024, and is projected to grow at a CAGR of 6.67%, to USD 22.62 billion by 2030.

The companion animal pharmaceuticals market encompasses drugs and medications designed specifically for pets, including dogs, cats, and other domesticated animals, addressing medical needs such as pain management, vaccination, anti-infectives, vaccines, parasiticides, and dermatological treatments. This sector is increasingly vital as pet ownership rises globally, driven by humanization trends where pets are viewed as family members, alongside concerns for animal health and wellness. Demand is propelled by advancing veterinary medicine, growing awareness of pet healthcare, and increased spending capability on pet-related services. The accessible market extends across veterinary clinics, home pharmacies, and online sales platforms. Key growth influencers include the increase in pet adoption rates, burgeoning veterinary infrastructure, technological advancements in drug formulations, and proliferation of chronic pet diseases. Opportunities arise from developing oral alternatives to injections, personalized medicine tailored to individual animals, and growth in emerging markets with rising pet adoption rates. However, market growth faces obstacles such as high cost of pharmaceuticals, stringent regulatory requirements for drug approval, and potential side effects of medications that could deter adoption. Economic slowdown impacts spending on pet healthcare, further challenging market expansion. Innovation can pivot around the development of eco-friendly, safe, and cost-effective medications, and leveraging biotechnology for novel therapeutics. Collaborative research between pharmaceuticals and veterinary institutions might offer breakthroughs in treatment efficacy and safety. Trending interest in therapeutic nutrition and wellness products supplementary to pharmaceuticals can also drive market exploration. The market is competitive and dynamic, characterized by rapid technological advancements and shifts in pet owner preferences, necessitating real-time market analysis and adaptive strategies to address demographic changes and evolving consumer needs. Companies successful in marrying innovation with consumer demand are poised to capture significant market share.

KEY MARKET STATISTICS
Base Year [2023] USD 14.39 billion
Estimated Year [2024] USD 15.28 billion
Forecast Year [2030] USD 22.62 billion
CAGR (%) 6.67%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Companion Animal Pharmaceuticals Market

The Companion Animal Pharmaceuticals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Prevalence of Zoonotic and Chronic Diseases
    • Rising Number of Companion Animals and Awareness About their Hygiene
    • Increasing Awareness and Expenditure Among People Regarding Animal Healthcare
  • Market Restraints
    • Several Risk Factors Associated with Companion Animal Health APIs
  • Market Opportunities
    • Development of New Drugs and Vaccines for Companion Animal
    • Strategic Collaborations Along with Emergence of Market Players Across the Developing Economies
  • Market Challenges
    • Stringent Regulations Associated with the Approval for Drugs

Porter's Five Forces: A Strategic Tool for Navigating the Companion Animal Pharmaceuticals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Companion Animal Pharmaceuticals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Companion Animal Pharmaceuticals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Companion Animal Pharmaceuticals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Companion Animal Pharmaceuticals Market

A detailed market share analysis in the Companion Animal Pharmaceuticals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Companion Animal Pharmaceuticals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Companion Animal Pharmaceuticals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Companion Animal Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Phibro Animal Health Corporation, Hipra Laboratories, S.A., Vetneeds Group, Neogen Corporation, Norbrook Laboratories Ltd., Tianjin Ringpu Biotechnology Co., Ltd., Stanex Drugs and Chemicals Pvt Ltd., Indian Immunologicals Ltd., Alivira Animal Health Limited, Kyoritsu Seiyaku Corporation, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, SkyEc Pharmaceuticals Private Limited, Endovac Animal Health, LLC, Lutim Pharma Pvt. Ltd., Virbac S.A., Ceva Sante Animale, Meiji Group, Boehringer Ingelheim International GmbH, Century Pharmaceuticals Ltd., Zydus Animal Health, Vetbiolix, Merck & Co. Inc., Veko Care, Ashish Life Science Pvt. Ltd., Chanelle Pharma, Zoetis Inc., Hester Biosciences Limited, Orion Corporation, and Eco Animal Health Group PLC.

Market Segmentation & Coverage

This research report categorizes the Companion Animal Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Analgesics, Anti-infectives, Anti-inflammatory, Medicated Feed Additives, Parasiticides, and Vaccines.
  • Based on Indication, market is studied across Behavioral Disorders, Dermatologic Diseases, Infectious Diseases, Orthopedic Diseases, and Pain.
  • Based on Animal Type, market is studied across Cats, Dogs, and Horses.
  • Based on Distribution Channel, market is studied across Online Pharmacies, Retail Pharmacies, Veterinary Clinics, and Veterinary Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Zoonotic and Chronic Diseases
      • 5.1.1.2. Rising Number of Companion Animals and Awareness About their Hygiene
      • 5.1.1.3. Increasing Awareness and Expenditure Among People Regarding Animal Healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. Several Risk Factors Associated with Companion Animal Health APIs
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of New Drugs and Vaccines for Companion Animal
      • 5.1.3.2. Strategic Collaborations Along with Emergence of Market Players Across the Developing Economies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent Regulations Associated with the Approval for Drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Diverse range of analgesics to treat general and chronic pain in companion animals
    • 5.2.2. Indication: Rising focus on developing advanced pharmaceuticals for antimicrobial resistance and infectious diseases in companion animals
    • 5.2.3. Animal Type: Increased adoption of dogs as companion animals and rising expenditure on their treatments
    • 5.2.4. Distribution Channel: Enhanced accessibility and convenience of attaining companion animal pharmaceuticals through online channels
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Companion Animal Pharmaceuticals Market, by Product

  • 6.1. Introduction
  • 6.2. Analgesics
  • 6.3. Anti-infectives
  • 6.4. Anti-inflammatory
  • 6.5. Medicated Feed Additives
  • 6.6. Parasiticides
  • 6.7. Vaccines

7. Companion Animal Pharmaceuticals Market, by Indication

  • 7.1. Introduction
  • 7.2. Behavioral Disorders
  • 7.3. Dermatologic Diseases
  • 7.4. Infectious Diseases
  • 7.5. Orthopedic Diseases
  • 7.6. Pain

8. Companion Animal Pharmaceuticals Market, by Animal Type

  • 8.1. Introduction
  • 8.2. Cats
  • 8.3. Dogs
  • 8.4. Horses

9. Companion Animal Pharmaceuticals Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Online Pharmacies
  • 9.3. Retail Pharmacies
  • 9.4. Veterinary Clinics
  • 9.5. Veterinary Hospitals

10. Americas Companion Animal Pharmaceuticals Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Companion Animal Pharmaceuticals Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Companion Animal Pharmaceuticals Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Boehringer Ingelheim Introduces NexGard SPECTRA in India, a New Chewable Solution for Comprehensive Dog Parasite Protection
    • 13.3.2. Zoetis Receives FDA Approval for Groundbreaking Canine Osteoarthritis and Allergy Treatments
    • 13.3.3. Akston Biosciences Shifts Focus to Pet Health, Using Cutting-Edge Technology to Develop New Treatments
    • 13.3.4. Zoetis Expands Global Reach with Acquisition of Jurox, Enhancing Veterinary Medication Portfolio for Companion and Livestock Care

Companies Mentioned

  • 1. Phibro Animal Health Corporation
  • 2. Hipra Laboratories, S.A.
  • 3. Vetneeds Group
  • 4. Neogen Corporation
  • 5. Norbrook Laboratories Ltd.
  • 6. Tianjin Ringpu Biotechnology Co., Ltd.
  • 7. Stanex Drugs and Chemicals Pvt Ltd.
  • 8. Indian Immunologicals Ltd.
  • 9. Alivira Animal Health Limited
  • 10. Kyoritsu Seiyaku Corporation
  • 11. Dechra Pharmaceuticals PLC
  • 12. Elanco Animal Health Incorporated
  • 13. SkyEc Pharmaceuticals Private Limited
  • 14. Endovac Animal Health, LLC
  • 15. Lutim Pharma Pvt. Ltd.
  • 16. Virbac S.A.
  • 17. Ceva Sante Animale
  • 18. Meiji Group
  • 19. Boehringer Ingelheim International GmbH
  • 20. Century Pharmaceuticals Ltd.
  • 21. Zydus Animal Health
  • 22. Vetbiolix
  • 23. Merck & Co. Inc.
  • 24. Veko Care
  • 25. Ashish Life Science Pvt. Ltd.
  • 26. Chanelle Pharma
  • 27. Zoetis Inc.
  • 28. Hester Biosciences Limited
  • 29. Orion Corporation
  • 30. Eco Animal Health Group PLC

LIST OF FIGURES

  • FIGURE 1. COMPANION ANIMAL PHARMACEUTICALS MARKET RESEARCH PROCESS
  • FIGURE 2. COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. COMPANION ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. COMPANION ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COMPANION ANIMAL PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COMPANION ANIMAL PHARMACEUTICALS MARKET DYNAMICS
  • TABLE 7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY BEHAVIORAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DERMATOLOGIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORTHOPEDIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY HORSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 197. COMPANION ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 198. COMPANION ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023